|
Market Closed -
NSE India S.E.
07:05:08 2026-10-28 EDT
|
5-day change | 1st Jan Change | ||
| 2,300.00 INR | +1.51% |
|
+4.06% | +13.01% |
| 09-11 | Glenmark Pharmaceuticals Limited Proposes Dividend for the Year Ended 31 March 2026 | CI |
| 09-07 | Acucort wins trademark protection for Zeqmelit in Ukraine | FW |
Chart calendar Glenmark Pharmaceuticals Limited
Upcoming events on Glenmark Pharmaceuticals Limited
| 2026-11-04 | Board of Directors Meeting | |
| 2026-11-05 | Earnings presentation | 22:00 |
| 2026-11-05 | Earnings release - Q2 2027 |
Past events on Glenmark Pharmaceuticals Limited
| 2026-09-11 | Annual General Meeting | 04:30 |
| 2026-09-11 | Présentation aux Actionnaires / Analystes | 04:30 |
| 2026-08-02 | Earnings presentation | 23:00 |
| 2026-07-31 | Board of Directors Meeting | 06:30 |
| 2026-07-31 | Earnings release - Q1 2027 | |
| 2026-06-30 | Présentation aux Actionnaires / Analystes | |
| 2026-06-29 | Présentation aux Actionnaires / Analystes | |
| 2026-06-08 | Analyst/Investor Day | |
| 2026-05-31 | Earnings presentation | 23:00 |
| 2026-05-29 | Earnings release - Q4 2026 | |
| 2026-05-29 | Board of Directors Meeting | 07:00 |
| 2026-02-01 | Earnings presentation | 22:00 |
| 2026-01-30 | Earnings release - Q3 2026 | |
| 2026-01-29 | Board of Directors Meeting | |
| 2025-11-16 | Earnings presentation | 22:00 |
| 2025-11-14 | Board of Directors Meeting | 03:30 |
| 2025-11-14 | Earnings release - Q2 2026 |
Past dividends on Glenmark Pharmaceuticals Limited
| 2026-08-31 | Ex-dividend date - 2.5 INR | 00:00 |
Annual results
| Fiscal Period | March | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 118 131 121 436 -2.72% | 133 217 134 532 -0.98% | 169 825 153 112 10.92% | 169 493 | 187 310 | 210 339 |
|
EBITDA Million INR | Released Forecast Spread | 11 953 12 869 -7.11% | 23 514 24 172 -2.72% | 45 724 35 985 27.07% | 36 398 | 43 540 | 48 545 |
|
EBIT Million INR | Released Forecast Spread | 6 134 7 400 -17.1% | 18 654 19 862 -6.08% | 39 989 32 587 22.71% | 30 630 | 36 990 | 39 859 |
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 365 -206 277.09% | 13 992 18 606 -24.8% | 19 847 22 239 -10.75% | 31 102 | 37 553 | 42 607 |
|
Net income Million INR | Released Forecast Spread | -15 017 33 363 -145.01% | 10 471 13 777 -24% | 13 619 20 532 -33.67% | 23 694 | 28 322 | 30 213 |
|
EPS INR | Released Forecast Spread | -53,2 25,4 -309.94% | 37,1 49,3 -24.79% | 48,2 65,9 -26.77% | 82,0 | 99,1 | 111 |
| Announcement Date | 24/05/24 | 23/05/25 | 29/05/26 | - |
Quarterly results
| Fiscal Period | March | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 S1 | 2027 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million INR | Released Forecast Spread | 34 338 34 831 -1.42% | 33 876 34 355 -1.4% | 32 562 33 190 -1.89% | 32 644 35 182 -7.21% | 60 469 52 067 16.14% | 39 006 38 601 1.05% | 37 706 38 424 -1.87% | 40 185 39 166 2.6% | 41 096 | ||
|
EBITDA Million INR | Released Forecast Spread | 6 019 6 523 -7.72% | 6 002 6 327 -5.13% | 5 610 5 948 -5.68% | 5 805 6 589 -11.9% | 23 596 21 665 8.91% | 8 697 9 867 -11.85% | 7 626 8 204 -7.05% | 8 048 7 935 1.42% | 8 003 | 16 231 | 19 057 |
|
EBIT Million INR | Released Forecast Spread | 4 816 5 289 -8.94% | 4 775 5 231 -8.72% | 4 358 4 666 -6.6% | 22 184 4 974 345.99% | |||||||
|
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 4 726 5 189 -8.93% | 4 563 5 186 -12.01% | 79,7 2 636 -96.97% | 9 674 46 794 -79.33% | 5 340 7 041 -24.16% | 3 878 7 084 -45.26% | 6 434 7 389 -12.93% | ||||
|
Net income Million INR | Released Forecast Spread | 3 542 3 657 -3.14% | 3 480 3 747 -7.14% | 46,5 3 195 -98.54% | 469 3 823 -87.74% | 6 104 24 974 -75.56% | 4 032 6 141 -34.34% | 3 014 5 538 -45.57% | 4 829 4 998 -3.38% | 4 896 | ||
|
EPS INR | Released Forecast Spread | 12,3 14,2 -13.17% | 14,3 18,1 -21.1% | |||||||||
| Announcement Date | 14/11/24 | 14/02/25 | 23/05/25 | 14/08/25 | 14/11/25 | 30/01/26 | 29/05/26 | 31/07/26 | - | - | - |
| Today |  | Earnings release - Q2 2027 | 23:00 |
| Today | | Earnings release - Q2 2027 | |
| 2026-10-29 | | Board of Directors Meeting | |
| Today | | Earnings presentation | 03:30 |
| 2026-10-29 | | Board of Directors Meeting | |
| 2026-10-29 | | Earnings release - Q2 2027 | |
| 2026-10-29 | | Board of Directors Meeting | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q2 2027 | |
| Today | | Earnings release - Q3 2026 |
Past sector events for Glenmark Pharmaceuticals Limited
| Today | | Board of Directors Meeting | |
| 2026-10-28 | | Earnings release - Q3 2026 | |
| 2026-10-28 | | Earnings release - Q3 2026 | |
| Today | | Board of Directors Meeting | |
| Today | | Board of Directors Meeting | |
| 2026-10-28 | | Earnings release - Q3 2026 | |
| 2026-10-28 | | Earnings release - Q3 2026 | |
| Today | | Earnings presentation | 20:01 |
| 2026-10-27 | | Sales and Revenue Release - Q3 2026 | |
| 2026-10-27 | | Earnings presentation | 06:30 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
- Calendar Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
